Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / KOD - Kodiak Initiates Phase 3 Trial And Other News: The Good Bad And Ugly Of Biopharma

KOD - Kodiak Initiates Phase 3 Trial And Other News: The Good Bad And Ugly Of Biopharma

Kodiak Sciences Inc
  • Kodiak Sciences reports initiation of Phase 3 trial of KSI-301.
  • Incyte announces peptide-centric strategic collaboration with Nimble.
  • AMAG receives a setback as the FDA rejects Makena.

For further details see:

Kodiak Initiates Phase 3 Trial, And Other News: The Good, Bad And Ugly Of Biopharma
Stock Information
Company Name: Kodiak Sciences Inc
Stock Symbol: KOD
Market: NASDAQ
Website: kodiak.com
Menu
KOD KOD Quote KOD Short KOD News KOD Articles KOD Message Board
Get KOD Alerts

News, Short Squeeze, Breakout and More Instantly...